Venture Certified
| 혁신성장유형 | 2022-06-22 ~ 2025-06-21 | 20220622030015 | - |
| 혁신성장유형 | 2025-06-22 ~ 2028-06-21 | 20250716030077 | 2025-07-16 |
Revenue CAGR +21.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3.5B | 3.3B | 2.4B |
| Operating Profit | 0.4B | -0.4B | -0.1B |
| Net Profit | 0.5B | 0.0B | 0.0B |
| Total Assets | 2.5B | 5.1B | 2.0B |
| Total Liabilities | 1.5B | 4.6B | 1.5B |
| Total Equity | 1.0B | 0.5B | 0.5B |
▲ 24.3%
▲ 236.4%
▲ 220.5%
▼ 73.6%
▲ 2435.2%
| Name | Position | Role |
|---|---|---|
| 박명금 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "박명금",
"certificate": [
{
"cert_number": "20220622030015",
"changes": "",
"disclosure_date": "2022-06-22",
"first_cert_date": "",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2022-06-22 ~ 2025-06-21"
},
{
"cert_number": "20250716030077",
"changes": "",
"disclosure_date": "2025-07-16",
"first_cert_date": "2025-07-16",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2025-06-22 ~ 2028-06-21"
}
],
"company_name": "(주)에니바이오",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 50000000,
"cost_of_sales": 100585000,
"current_assets": 57810000,
"current_liabilities": 146673000,
"gross_profit": 139515000,
"net_income": 1372000,
"net_income_bs": 1193000,
"non_current_assets": 141840000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 9115000,
"operating_profit": -7743000,
"revenue": 240100000,
"sga_expenses": 147258000,
"total_assets": 199650000,
"total_equity": 52977000,
"total_liabilities": 146673000
},
"2023": {
"capital_stock": 50000000,
"cost_of_sales": 124306000,
"current_assets": 371481000,
"current_liabilities": 459738000,
"gross_profit": 206917000,
"net_income": 607000,
"net_income_bs": 607000,
"non_current_assets": 141840000,
"non_current_liabilities": 0,
"non_operating_expenses": 3300000,
"non_operating_income": 48657000,
"operating_profit": -44750000,
"revenue": 331223000,
"sga_expenses": 251667000,
"total_assets": 513321000,
"total_equity": 53584000,
"total_liabilities": 459738000
},
"2024": {
"capital_stock": 50000000,
"cost_of_sales": 187832000,
"current_assets": 139451000,
"current_liabilities": 150540000,
"gross_profit": 167125000,
"net_income": 47459000,
"net_income_bs": 46990000,
"non_current_assets": 111663000,
"non_current_liabilities": 0,
"non_operating_expenses": 4797000,
"non_operating_income": 16465000,
"operating_profit": 35791000,
"revenue": 354957000,
"sga_expenses": 131334000,
"total_assets": 251114000,
"total_equity": 100574000,
"total_liabilities": 150540000
}
},
"industry": "화장품 제조업",
"investment": [],
"main_products": "입욕제,암염골드앰플,salt'Q",
"phone": "042-933-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |